Yishan Lei Selected Research

2- amino- 4- (4- fluoronaphth- 1- yl)- 6- isopropylpyrimidine

1/2019

Anxiety-induced hyperalgesia in female rats is mediated by cholecystokinin 2 receptor in rostral ventromedial medulla and spinal 5-hydroxytryptamine 2B receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yishan Lei Research Topics

Disease

8	Hyperalgesia 01/2020 - 01/2016
8	Pain (Aches) 01/2019 - 01/2015
5	Postoperative Pain 01/2021 - 03/2016
3	Bone Neoplasms (Bone Cancer) 01/2018 - 01/2015
2	Chronic Pain 01/2021 - 01/2017
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2017 - 01/2016
2	Neoplasms (Cancer) 01/2016 - 01/2015
1	Osteosarcoma (Osteogenic Sarcoma) 01/2018
1	Inflammation (Inflammations) 08/2017
1	Spinal Cord Compression 08/2017
1	Spinal Cord Injuries (Spinal Cord Injury) 08/2017
1	Surgical Wound 01/2017
1	Hypersensitivity (Allergy) 01/2017
1	Neuralgia (Stump Neuralgia) 11/2016
1	Postherpetic Neuralgia 11/2016

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 01/2017 - 01/2016
3	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 08/2017 - 01/2017
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2016 - 01/2016
2	Dexmedetomidine FDA Link 01/2021 - 08/2017
2	Analgesics (Analgesic Drugs)IBA 01/2021 - 01/2017
2	1- (5- chloro- 2,4- dimethoxyphenyl)- 3- (5- methylisoxazol- 3- yl)ureaIBA 01/2019 - 01/2017
2	N- (1- azabicyclo(2.2.2)oct- 3- yl)furo(2,3- c)pyridine- 5- carboxamideIBA 01/2019 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 11/2016
2	Minocycline (Cyclops)FDA LinkGeneric 01/2017 - 01/2016
2	Remifentanil (Ultiva)FDA Link 01/2017 - 01/2017
2	salicylhydroxamic acid (SHAM)IBA 01/2016 - 01/2015
2	bovine adrenal medulla 8-22IBA 01/2016 - 01/2015
1	EsketamineIBA 01/2021
1	Estrogen ReceptorsIBA 01/2020
1	GTP-Binding Proteins (G-Protein)IBA 01/2020
1	N-Methylaspartate (NMDA)IBA 01/2019
1	methyllycaconitineIBA 01/2019
1	Sincalide FDA Link 01/2019
1	Protein Kinases (Protein Kinase)IBA 01/2019
1	Cholecystokinin (Pancreozymin)IBA 01/2019
1	Cholecystokinin B ReceptorIBA 01/2019
1	5-HT2B Serotonin ReceptorIBA 01/2019
1	2- amino- 4- (4- fluoronaphth- 1- yl)- 6- isopropylpyrimidineIBA 01/2019
1	1- (5- (2- thenyloxy)- 1H- indol- 3- yl)propan- 2- amineIBA 01/2019
1	YM 022IBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	dehydrocorydalinIBA 01/2018
1	Toll-Like Receptor 4IBA 08/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	tyrosine receptor (receptor, tyrosine)IBA 01/2017
1	Glial Fibrillary Acidic ProteinIBA 01/2017
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2017
1	Opioid Analgesics (Opioids)IBA 01/2017
1	Mitogen-Activated Protein KinasesIBA 01/2017
1	N- (4- methylthiazol- 2- yl)- 2- (6- phenylpyridazin- 3- ylthio)acetamideIBA 01/2017
1	Cholinergic ReceptorsIBA 01/2017
1	InterleukinsIBA 01/2017
1	GlucocorticoidsIBA 01/2017
1	resiniferatoxinIBA 11/2016
1	Ketamine FDA LinkGeneric 03/2016
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2015

Therapy/Procedure

3	Spinal Injections 01/2019 - 01/2016
2	Therapeutics 01/2017 - 01/2017
1	General Anesthesia 01/2021
1	Injections 01/2019
1	Perioperative Period 01/2019
1	Anesthesia 01/2017
1	Electroacupuncture 01/2017
1	Intraperitoneal Injections 11/2016